Israeli researchers have developed a medication that, if taken as an infusion, has the potential to cure the human immunodeficiency virus (HIV).
According to Dr. Adi Barzel of Tel Aviv University, the physicians generated type B white blood cells outside the body, a method that has only been achieved a few times.
These genetically modified cells stimulate the immune system to produce antibodies that neutralize HIV.
“Based on this research, we expect to be able to produce a medication for acquired immunodeficiency syndrome (AIDS), additional infectious diseases, and certain types of cancer caused by a virus, such as cervical cancer, head and neck cancer, and others in the coming years,” Dr. Barzel said in a university release.
While various therapies are available to mitigate the consequences of the potentially lethal infection, there is no permanent cure. This new medicine, on the other hand, offers hope to HIV patients.